Artelo Biosciences Inc (ARTL)
NASDAQ:ARTL
US Market
Holding ARTL?
Track your performance easily

Artelo Biosciences (ARTL) Financial Statements

467 Followers

Artelo Biosciences Financial Overview

Artelo Biosciences's market cap is currently ―. The company's EPS TTM is $-3.324; its P/E ratio is -0.36; Artelo Biosciences is scheduled to report earnings on March 26, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -2.43M$ -2.48M$ -3.07M$ -2.45M$ -1.60M
EBITDA$ -2.43M$ -2.48M$ -3.07M$ -2.45M$ -1.60M
Net Income Common Stockholders$ -2.43M$ -2.48M$ -3.07M$ -2.45M$ -1.60M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 4.72M$ 6.41M$ 7.61M$ 10.22M$ 8.27M
Total Assets$ 8.33M$ 10.35M$ 13.04M$ 15.50M$ 16.88M
Total Debt$ 120.00K$ 127.00K$ 23.00K$ 32.00K$ 40.00K
Net Debt$ -4.60M$ -6.29M$ -7.59M$ -10.19M$ -8.23M
Total Liabilities$ 1.03M$ 817.00K$ 1.29M$ 921.00K$ 609.00K
Stockholders Equity$ 7.30M$ 9.54M$ 11.75M$ 14.58M$ 16.27M
Cash Flow-
Free Cash Flow$ -2.06M$ -2.94M$ -2.60M$ -1.80M$ -1.62M
Operating Cash Flow$ -2.06M$ -2.94M$ -2.60M$ -1.80M$ -1.62M
Investing Cash Flow$ 1.75M$ 1.27M$ 2.74M$ -1.83M$ 399.00K
Financing Cash Flow-$ 55.00K$ 32.00K$ 535.00K-
Currency in USD

Artelo Biosciences Earnings and Revenue History

Artelo Biosciences Debt to Assets

Artelo Biosciences Cash Flow

Artelo Biosciences Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis